By Abigail Townsend
Date: Wednesday 07 May 2025
(Sharecast News) - Shares in GSK and AstraZeneca came under pressure on Wednesday, after vaccine-sceptic Vinay Prasad was appointed to a key role at the US Food and Drug Administration.
Currency | US Dollars |
Share Price | $ 715.20 |
Change Today | $ -9.75 |
% Change | -1.34 % |
52 Week High | $960.02 |
52 Week Low | $711.55 |
Volume | 4,248,457 |
Shares Issued | 948.17m |
Market Cap | $678,131m |
Beta | 0.78 |
RiskGrade | 179 |
Strong Buy | 11 |
Buy | 10 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
16:00 | 375,840 @ $715.20 |
16:00 | 501 @ $715.10 |
16:00 | 490 @ $715.10 |
16:00 | 804 @ $715.15 |
16:00 | 861 @ $715.14 |
You are here: research